​
Login / Signup
Xu Feng
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
High Throughput
Systematic Review
Deep Learning
Meta Analyses
Top Venues
Immunotherapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xueyin Zhou
,
Jiasheng Cao
,
Win Topatana
,
Tian-Ao Xie
,
Tianen Chen
,
Jiahao Hu
,
Shijie Li
,
Sarun Juengpanic
,
Ziyi Lu
,
Bin Zhang
,
Kaitai Wang
,
Xu Feng
,
Jiliang Shen
,
Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis.
Immunotherapy
(2023)
Xueyin Zhou
,
Jiasheng Cao
,
Win Topatana
,
Tian-Ao Xie
,
Tianen Chen
,
Jiahao Hu
,
Shijie Li
,
Sarun Juengpanic
,
Ziyi Lu
,
Bin Zhang
,
Kaitai Wang
,
Xu Feng
,
Jiliang Shen
,
Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis.
Immunotherapy
15 (5) (2023)
Xueyin Zhou
,
Jiasheng Cao
,
Win Topatana
,
Tian-Ao Xie
,
Tianen Chen
,
Jiahao Hu
,
Shijie Li
,
Sarun Juengpanic
,
Ziyi Lu
,
Bin Zhang
,
Kaitai Wang
,
Xu Feng
,
Jiliang Shen
,
Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis.
Immunotherapy
15 (5) (2023)